Chan Mitchell 4
4 · Avalo Therapeutics, Inc. · Filed Dec 3, 2021
Insider Transaction Report
Form 4
Chan Mitchell
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-12-01+80,000→ 80,000 totalExercise: $1.87Exp: 2031-12-01→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in three substantially equal installments on December 1, 2022, December 1, 2023 and December 1, 2024, subject to the Reporting Person's continued service on each such vesting date.